Correspondence 0001104659-23-119092 from TELA Bio, Inc. (TELA) (CIK 0001561921) (TELA)

TELA Bio, Inc. (TELA) (CIK 0001561921)
Date: Nov. 16, 2023 · CIK: 0001561921 · Accession: 0001104659-23-119092

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-275511

Date

November 16, 2023

Author

Form

CORRESP

Company

TELA Bio, Inc. (TELA) (CIK 0001561921)

Letter

TELA Bio, Inc.

1 Great Valley Parkway, Suite 24

Malvern, Pennsylvania 19355

November 16, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, D.C. 20549

Re: TELA Bio, Inc.

Registration Statement on Form S-3

SEC File No. 333-275511

Filed November 13, 2023

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-275511) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:05 PM, eastern time, on November 20, 2023, or as soon thereafter as is practicable.

Please feel free to direct any questions or comments concerning this request to Justin S. Platt, Esq. of Goodwin Procter LLP at (212) 459-7340.

Sincerely,
TELA BIO, Inc.

Show Raw Text

CORRESP
1
filename1.htm

TELA
Bio, Inc.

1 Great Valley Parkway, Suite 24

Malvern, Pennsylvania 19355

November 16, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    TELA Bio, Inc.

Registration Statement on Form S-3

SEC File No. 333-275511

Filed November 13, 2023

Ladies and Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date
of the Company’s Registration Statement on Form S-3 (File No. 333-275511) (the “Registration Statement”)
be accelerated so that the Company’s Registration Statement will become effective at 4:05 PM, eastern time, on November 20,
2023, or as soon thereafter as is practicable.

Please feel free to direct any
questions or comments concerning this request to Justin S. Platt, Esq. of Goodwin Procter LLP at (212) 459-7340.

    Sincerely,

    TELA BIO, Inc.

    By:
    /s/ Antony Koblish

    Name: Antony Koblish

    Title: President and Chief Executive Officer

Cc: Justin S. Platt, Goodwin Procter LLP

SecProbe.io